Adjuvant Systemic Therapy

DRUG3 trials

Sponsors

Shandong Cancer Hospital and Institute, Case Comprehensive Cancer Center, National Medical Research Radiological Centre of the Ministry of Health of Russia

Conditions

Breast CancerEarly Breast CancerHER2-positive Breast CancerMalignant Neoplasm of BladderMuscle Invasive Bladder Carcinoma

Phase 2

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

RecruitingNCT06290687

Case Comprehensive Cancer CenterMalignant Neoplasm of Bladder, Muscle Invasive Bladder Carcinoma

Start: 2025-02-18End: 2027-12-29Target: 40Updated: 2026-02-18

De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer

Active, not recruitingNCT07421141

National Medical Research Radiological Centre of the Ministry of Health of RussiaBreast Cancer, Early Breast Cancer, HER2-positive Breast Cancer

Start: 2023-09-01End: 2028-12-30Updated: 2026-02-27

Phase 3

Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

WithdrawnNCT01796444

Shandong Cancer Hospital and InstituteBreast Cancer

Start: 2013-01-31End: 2026-06-30Updated: 2018-04-05

Related Papers

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.

2018-12-04108 citations